Overall rank by patents
#12,100
of 50,000 tracked assignees
USPTO PatentsView assignee record - 25 granted patents across 0 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.
The verdict
According to USPTO PatentsView, London ranks #12,100 of 50,000 tracked US assignees by granted-patent volume, with 25 patents across 0 technology areas.
London Johnson, Inc. has been granted 25 US utility patents between 2017 and 2021, placing London Johnson, Inc. at #12,100 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 0 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent. As a US Corporation, London Johnson, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, London sits between Leibniz-institut Für Neue Materialien Gemeinnützige Gmbh (25 patents, rank #12,097) and MAPI Pharma Ltd. (25 patents, rank #12,105) - the closest US assignees by grant volume. The composite Innovation Score of 11.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 6 grants, compared with 19 in the 2015–2019 window, a -68% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. London Johnson, Inc.'s 1.0 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 0 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Leibniz-Institut für Neue Materialien gemeinnützige GmbH
25 patents
Linvatec Corporation
25 patents
Liquid Robotics, Inc.
25 patents
LogMeIn, Inc.
25 patents
Luminous Computing, Inc.
25 patents
Luna Innovations Incorporated
25 patents
Lyco Manufacturing, Inc.
25 patents
MAPI PHARMA LTD.
25 patents
London Johnson, Inc.
25 patents
What this shows London holds 25 patents at rank #12,101, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #12,101 in granted patent volume.
London's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
12 Top 98% higher than 2% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 4 | 16.0% |
| 2018 | 8 | 32.0% |
| 2019 | 7 | 28.0% |
| 2020 | 4 | 16.0% |
| 2021 | 2 | 8.0% |
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#12,100
of 50,000 tracked assignees
11.8 out of 100
How to use this portfolio
London's 25 grants land it in the top 98% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.